Fresh Intravenous Blood Samples for TBI Diagnostic Assay Development With Philips Point of Care System
- Conditions
- Traumatic Brain Injury
- Interventions
- Other: Blood draw within 12 hours of injury
- Registration Number
- NCT03060109
- Lead Sponsor
- Banyan Biomarkers, Inc
- Brief Summary
The purpose of this study is to collect fresh whole blood within 12 hours from suspected mild head injury (Glasgow Coma Scale score 13-15) from subjects over the age of 18, to help verify that both UCH-L1 and GFAP can be detected with the Philips Minicare POC diagnostic test platform.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 317
- The Subject is at least 18 years of age at screening.
- The Subject has presented to a Health Care Facility or Emergency Department with a suspected traumatically induced head injury, as a result of insult to the head from an external force.
- The Subject has a Glasgow Coma Scale score of 13-15 at the time of Informed Consent.
- The venous blood sample is collected no later than 12 hours from the time of head injury.
- The Subject is competent and willing to undergo the Informed Consent process
- Participating in any other interventional, therapeutic clinical study (an observational study would be acceptable).
- Time of suspected head injury cannot be determined.
- Venipuncture not feasible (i.e., skin integrity compromised at the venipuncture sites, blood vessel calcification (i.e., IV drug users, advanced atherosclerosis) both upper limbs missing (congenital or amputee)).
- Blood transfusion after head injury, and prior to study blood draw
- Blood donation within 1 week of study enrollment.
- The subject is a female who is pregnant or lactating.
- The Subject is otherwise determined by the Principal Investigator to be an unsuitable candidate for participation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Suspected traumatic brain injury Blood draw within 12 hours of injury -
- Primary Outcome Measures
Name Time Method Measurement of biomarkers 12 hours Measurement of UCH-L1 and GFAP using Philips Minicare
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
Radboud University Medical Center
🇳🇱Nijmegen, Netherlands
Maastricht University Medical Center
🇳🇱Maastricht, Netherlands
Erasmus Medical Center
🇳🇱Rotterdam, Netherlands
Haaglanden MC Westeinde
🇳🇱The Hague, Netherlands